Given the lack of effective tools available for observing EGD, researchers sought to develop an AI-assisted EGD system to automatically monitor the entire stomach in real time and maintain a record of the procedure time.
Population-based analysis identified trends in incidence and disease-free survival for patients with advanced-stage carcinoma across 3 age groups.
The incidence of young-onset esophageal adenocarcinoma is increasing, and patients present at more advanced stages compared with older patients.
Results presented at the European Society for Medical Oncology Virtual Congress 2020showed significant improvements in the primary endpoints for the pembrolizumab group.
Investigators compared the histological outcomes of endoscopic submucosal dissection with those of cap-assisted endoscopic mucosal resection.
The FDA has accepted for review the NDA and granted Priority Review to TAK-721 (budesonide oral suspension) for the treatment of eosinophilic esophagitis.
Investigators assessed whether recurrent gastroesophageal junction intestinal metaplasia is associated with increased risk for subsequent dysplasia and whether endoscopic treatment lowers this risk if so.
Investigators tested the safety and efficacy of dupilumab in adults and adolescents with eosinophilic esophagitis (EoE) in a randomized phase 3 trial.
Five Prime Therapeutics, Inc. announced topline data from the phase 2 FIGHT study comparing bemarituzumab and chemotherapy with chemotherapy alone.
End-stage lung disease may significantly increase the risk for gastroesophageal reflux disease (GERD) in patients undergoing lung transplant without primary esophageal disease.
